Abata Therapeutics is a clinical-stage biotech company dedicated to transforming lives with Treg therapies for severe autoimmune and inflammatory diseases. Founded by pioneers in Treg biology, TCR and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers, Abata has developed a differentiated product engine to create a pipeline of novel engineered Treg cell therapies that are tissue-specific, robust, and durable. Abata’s lead programs are in progressive multiple sclerosis and type 1 diabetes – tissue-specific autoimmune diseases with substantial unmet need, supporting a strong rationale for Abata’s Treg approach. Abata is based in Watertown, Mass.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Watertown, Ma 02472, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.abatatx.com
- Keywords
- Manager jobs.
- HQ
- Watertown, MA
Abata Therapeutics Questions
Abata Therapeutics's website is http://www.abatatx.com
Abata Therapeutics's LinkedIn profile is https://www.linkedin.com/company/abata-therapeutics
Abata Therapeutics has
7 employees.
View email and phone details for 7
employees at Abata Therapeutics.
Abata Therapeutics's industry is
Biotechnology Research
Abata Therapeutics's top competitors are
Elevatebio,
Coya Therapeutics, Inc.,
Affini-T Therapeutics,
Tessera Therapeutics,
Yoltech Therapeutics,
Moma Therapeutics,
Vigil Neuroscience,
Beam Therapeutics,
Gentibio,
Remix Therapeutics.
Abata Therapeutics's categories are Biotechnology Research
Abata Therapeutics's founding year is 2021
